This study investigates the outcomes of patients who underwent photorefractive keratectomy (PRK) followed immediately by standard 30-minute corneal crosslinking (CXL) for keratoconus. Source: AAO
Horizon Pharma announced positive topline results in a confirmatory phase 3 trial evaluating teprotumumab for active thyroid eye disease (TED). Source: AAO
This retrospective study assessed cases of acute vascular ischemic events occurring in patients with central retinal artery occlusion (CRAO). Source: AAO
Investigators retrospectively report the structural and functional outcomes of autologous neurosensory retinal transplant for refractory large macular holes. Source: AAO
This week, Roche plans to acquire Spark Therapeutics for $4.3 billion, MedPage ranks ophthalmologists’ salaries 15th among 25 specialties and a mouse model accelerates research on a rare retinal disease. Source: AAO
Investigators compared visual acuity in patients with neovascular AMD tolerating some subretinal fluid (SRF) with those undergoing treatment to resolve all SRF. Source: AAO
This study compared the effectiveness of topical 5-fluorouracil 1% (5FU) versus interferon alfa-2b eye drops as primary treatment modalities for ocular surface squamous neoplasia. Source: AAO
This study describes the natural history of meningiomas confined to the cavernous sinus (MCSs) to better inform the choice of treatment. Source: AAO
Bausch + Lomb’s new formulation of loteprednol etabonate ophthalmic gel, Lotemax SM 0.38%, has been cleared by the FDA for postoperative pain and inflammation. Source: AAO
Researchers report the regression patterns experienced by patients after off-label intravitreal bevacizumab therapy for retinopathy of prematurity (ROP). Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
